Tigermed
A contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Launch date
Market cap
CAD7.1b
Enterprise valuation
CAD7.3b (Public information from Sep 2024)
Share price
HKD27.05 3347.HK
Hangzhou Zhejiang (HQ)
No columns specified